Quantum Surgical, an innovative company developing a Surgical Robot for liver cancer treatment, announces today that the company has obtained a €4.8 million State Guaranteed Loan (PGE).
This loan, granted by Crédit Agricole, Dupuy de Parseval Bank, and the French Public Bank for Investment (BPI) as part of the measures to support the economy, will enable the company to pursue the development of its product which is expected to be commercialized in 2021 in Europe.
“Thanks to our partner banks and the BPI who quickly mobilized to grant us this loan, and thus confirm their confidence in our project, we will be able to continue our development activities aimed at obtaining Regulatory authorizations of our robotic platform needed before its commercialization” announces Christophe Sibillin, Chief Financial Officer at Quantum Surgical.
Quantum Surgical in a few words
Co-founded in 2017 by Bertin Nahum, Quantum Surgical is an innovative surgical robotic company based in Montpellier (France). Quantum Surgical’s robotic solution is a combination of powerful software and robotic platform for minimally invasive therapies in liver cancer. This platform combining robotics, image analytics, and artificial intelligence will allow more and more patients to benefit from safer interventional oncology procedures, especially in the case of early-stage liver cancers. The incidence of liver cancer in the population is, unfortunately, growing very rapidly. Liver cancer is one of the most common cancers with more than 800,000 cases each year in the world. Quantum Surgical is backed by leading global life science investment fund Ally Bridge Group since inception.
Further information is available on our website: https://quantumsurgical.com
